Navigation Links
Anne Glover and Sir Michael Stratton to meet the press at The EMBO Meeting 2013 in Amsterdam
Date:7/17/2013

HEIDELBERG -- Predisposition to cancer and other diseases, genetic testing, infectious proteins and ubiquitin signalling -- these are some of the topics internationally renowned speakers will tackle at The EMBO Meeting 2013 to be held in Amsterdam, the Netherlands, from 21-24 September 2013.

Sir Michael Stratton, Director of the Wellcome Trust Sanger Institute, Kri Stefnsson, Chief Executive Officer of deCODE Genetics, and Thijn Brummelkamp, Group Leader at the Netherlands Cancer Institute and winner of the 2013 EMBO Gold Medal, will discuss The Future of Cancer Genomics in an exclusive press conference for journalists and science writers from 11-12 am on Monday 23 September.

On the same day, Anne Glover, Chief Scientific Adviser to Jos Manuel Barroso, President of the European Commission, will be talking to journalists in a Meet the Press event at 6.00 pm.

Sessions on epigenetics, vaccines, stem cell signalling and European science policy are also part of the programme for The EMBO Meeting.

The EMBO Meeting first took place in Amsterdam in 2009, when the conference attracted more than 1300 participants from 50 countries. Attendees at this year's meeting will include researchers at all stages of their scientific career. Policy makers, editors, career advisors, journalists, science bloggers and exhibitors from industry will also be attending the conference.

The EMBO Meeting 2013 will offer plenaries and concurrent sessions by first-rate speakers. Media participants will have multiple opportunities to cover news and also gather ideas for future stories:

  • At a keynote lecture at 9:00am on Monday, 23 September, Hans Clevers will discuss the challenges in identifying and targeting tumour stem cells (Lgr5 stem cells in self-renewal and cancer).

  • The Women in Science session features award-winning Australian writer Cordelia Fine, a psychologist with interests in neuroscience and gender. Her latest book, Delusions of gender: The real science behind sex differences, was short-listed for the Victorian Premier's Literary Award for Non-Fiction, the Best Book of Ideas Prize 2011 and the John Llewellyn Rhys Prize 2010.

  • The Special Lecture explores the question Is there life on other planets? Christopher McKay who is Planetary Scientist with the Space Science Division of NASA, will deliver an update about the Mars Curiosity Rover.

  • The role of ubiquitin signalling in cancer is the topic of Vishva Dixit, Vice President of Physiological Chemistry at Genentech, part of the Roche Group, and Adjunct Professor at the University of California, San Francisco.

  • Albert Osterhaus is one of the speakers at the concurrent session on vaccines on Tuesday 24 September from 9-11 am. His team played an important role in the identification of the SARS virus in the Hong Kong outbreak in 2002 and was one of the first to identify human infection with the avian influenza strain H5N1.

  • The full programme is available at http://www.the-embo-meeting.org. Online press registration and more information for journalists is available at: http://www.the-embo-meeting.org/press.html. The Abstract Book will be emailed to registered participants and journalists two weeks before the conference starts. Interview opportunities can be arranged prior to the conference or on site, beginning on Saturday evening after the opening address.


'/>"/>

Contact: Barry Whyte
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. Brupbacher Prize goes to cancer researcher Michael Karin
2. Researchers and company from Luxembourg awarded a grant from Michael J. Fox Foundation
3. Michael Barnett of Boston College named Professor of the Year for Massachusetts
4. Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinsons drug development tools
5. AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
6. Carnegie Mellon researchers develop artificial cells to study molecular crowding and gene expression
7. Artifact suppression and analysis of brain activities with EEG signals
8. Pressure cooker on steroids treats human waste
9. A calculator to estimate the likelihood of antidepressant response
10. Observing live gene expression in the body
11. Efficacy of acupressure to relieve migraine nausea presented at International Headache Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... June 22, 2016 On Monday, the Department ... industry to share solutions for the Biometric Exit Program. ... and Border Protection (CBP), explains that CBP intends to ... the United States , in order ... defeat imposters. Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... June 23, 2016 On Wednesday, June ... 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% ... at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the ... Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. ... BIND ). Learn more about these stocks by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
Breaking Biology Technology: